Awardee OrganizationSALK INSTITUTE FOR BIOLOGICAL STUDIES
Description
Abstract Text
Transgenic and knockout mouse models have become an integral part ofthe research programs at Salk. The Transgenic Core is dedicated to providing access to cutting-edge technologies to create these models. Core services include microinjection of DNA constructs into one-cell stage embryos, microinjection of gene targeted mouse embryonic stem (ES) cells into blastocysts, lentiviral infection and injection, in-vitro fertilization (IVF), cryopreservation and rederivation of mouse lines. In addition, the Core offers injection of human embryonic stem (hES) cell lines and induced pluripotent stem (IPS) cell lines into immunodeficient mice to form teratomas.
The Transgenic Core develops new techniques and applications, provides immediate access to individuals with knowledge of dealing with transgenic mice, and offers the potential for research collaborations. More than 100 publications were based on genetically altered mouse lines created by the Transgenic Core since 1994.
All CCSG supported core are organized into one group: Basic Research.
This shared resource is categorized as category (1.03) Transgenic Animal Facility in summary ID
Public Health Relevance Statement
RELEVANCE (See instructions):
The study of human cancer requires the development of animal models that recapitulate human disease. This resource will focus on development mouse models for Cancer Center research programs.
No Sub Projects information available for 5P30CA014195-42 7764
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5P30CA014195-42 7764
Patents
No Patents information available for 5P30CA014195-42 7764
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5P30CA014195-42 7764
Clinical Studies
No Clinical Studies information available for 5P30CA014195-42 7764
News and More
Related News Releases
No news release information available for 5P30CA014195-42 7764
History
No Historical information available for 5P30CA014195-42 7764
Similar Projects
No Similar Projects information available for 5P30CA014195-42 7764